Cercar
01/10/2022
Characteristics of subjective cognitive decline associated with amyloid positivity
Janssen, O, Jansen, WJ, Vos, SJB, Boada, M, Parnetti, L, Gabryelewicz, T, Fladby, T, Molinuevo, JL, Villeneuve, S, Hort, J, Epelbaum, S, Lleo, A, Engelborghs, S, van der Flier, WM, Landau, S, Popp, J, Wallin, A, Scheltens, P, Rikkert, MO, Snyder, PJ, Rowe, C, Chetelat, G, Ruiz, A, Marquie, M, Chipi, E, Wolfsgruber, S, Heneka, M, Boecker, H, Peters, O, Jarholm, J, Rami, L, Tort-Merino, A, Binette, AP, Poirier, J, Rosa-Neto, P, Cerman, J, Dubois, B, Teichmann, M, Alcolea, D, Fortea, J, Sanchez-Saudinos, MB, Ebenau, J, Pocnet, C, Eckerstrom, M, Thompson, L, Villemagne, V, Buckley, R, Burnham, S, Delarue, M, Freund-Levi, Y, Wallin, AK, Ramakers, I, Tsolaki, M, Soininen, H, Hampel, H, Spiru, L, Tijms, B, Ossenkoppele, R, Verhey, FRJ, Jessen, F, Visser, PJ. Characteristics of subjective cognitive decline associated with amyloid positivity. ALZHEIMERS & DEMENTIA. 2022; 18(10)DOI:10.1002/alz.12512. PMID:34877782. IF:14.000(Q1/1D).
13/03/2024
Adapting prescribing criteria for amyloid-targeted antibodies for adults with Down syndrome
Hillerstrom, H, Fisher, R, Janicki, MP, Chicoine, B, Christian, BT, Esbensen, A, Esralew, L, Fortea, J, Hartley, S, Hassenstab, J, Keller, SM, Krinsky-McHale, S, Lai, FRC, Levin, J, Mccarron, M, Mcdade, E, Rebillat, AS, Rosas, HD, Silverman, W, Strydom, A, Zaman, SH, Zetterberg, H. Adapting prescribing criteria for amyloid-targeted antibodies for adults with Down syndrome. ALZHEIMERS & DEMENTIA. 2024; 20(5)DOI:10.1002/alz.13778. PMID:38480678. IF:11.100(Q1/1D).
01/03/2026
Subphenotype-and complication-guided adjunctive fosfomycin versus standard monotherapy in Staphylococcus aureus bacteraemia: pooled analysis of two randomised trials
Escrihuela-Vidal, F, Larrauri, JG, López-Contreras, J, Euba, G, Vázquez, A, Gómez-Zorrilla, S, López-Cortés, LE, Gasch, O, Aparicio-Minguijón, E, Escudero-Sànchez, R, Pérez-Rodríguez, MT, Rodríguez-Pardo, D, Jover-Sáenz, A, García-Pardo, G, Rodríguez-Baño, J, Pujol, M, Carratalà, J, Gutiérrez-Gutiérrez, B. Subphenotype-and complication-guided adjunctive fosfomycin versus standard monotherapy in Staphylococcus aureus bacteraemia: pooled analysis of two randomised trials. Lancet Regional Health-Europe. 2026; 62DOI:10.1016/j.lanepe.2026.101611. PMID:41788427. IF:13.000(Q1/1D).
15/02/2026
Adjunctive Fosfomycin for the Treatment of Staphylococcus aureus Bacteremia: A Pooled Post Hoc Analysis of Individual Participant Data From 2 Randomized Trials
Escrihuela-Vidal, F, Ong, SWX, Oriol, I, Grillo, S, Pujol, M, Pallarès, N, Tebé, C, Liu, K, Miro, JM, Tong, SYC, Carratalà, J. Adjunctive Fosfomycin for the Treatment of Staphylococcus aureus Bacteremia: A Pooled Post Hoc Analysis of Individual Participant Data From 2 Randomized Trials. CLINICAL INFECTIOUS DISEASES. 2026; 82(2)DOI:10.1093/cid/ciaf387. PMID:40670317. IF:7.300(Q1/1D).
01/02/2026
The role of artificial intelligence in predicting graft survival in kidney transplantation: a systematic review
Di Bello, F, Gallioli, A, Pecoraro, A, Prudhomme, T, Piana, A, Marco, BB, Haberal, HB, Dönmez, MI, Lopez-Abad, A, Cannoletta, D, Mancon, S, Guirado, L, Facundo, C, Kanashiro, AK, Gavrilov, P, Rodriguez-Faba, O, Gaya, JM, Breda, A, Territo, A. The role of artificial intelligence in predicting graft survival in kidney transplantation: a systematic review. Minerva Urology And Nephrology. 2026; 78(1)DOI:10.23736/S2724-6051.25.06559-0. PMID:41697205. IF:4.200(Q1/2D).
01/02/2026
Risk factors associated with inadequacy of empirical treatment in patients with sepsis and bacteremia attended in an emergency department
Motos-Bescós, M, Ruiz-Ramos, J, Agra-Montava, I, Moliné-Pareja, A, Palacio-Alvarez, P, Villarejo-Jiménez, A, Pomar-Solchaga, V. Risk factors associated with inadequacy of empirical treatment in patients with sepsis and bacteremia attended in an emergency department. Revista Espanola de Quimioterapia. 2026; 39(1)DOI:10.37201/req/101.2025. PMID:41521957. IF:2.200(Q3/6D).